JPRN-UMIN000024399已完成未知
The study of ANagliptin effects on Glucagon LEvels of type 2 DM patients using insulin / ANGLE study - The study of ANagliptin effects on Glucagon LEvels of type 2 DM patients using insulin (ANGLE study)
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients who fall into any of the following criteria are unable to participate in the study. 1. Patients with type 1 diabetes mellitus 2. Patients with insulin dose increased 4 units during the observation times [-12 weeks from baseline] 3. Patients with kind of insulin preparation changed during the observation times 4. Patients who have an experience of taking anagliptin in the past 5. Patients with BMI 30 kg/m2 or greater 6. Patients with severe liver impairment (e.g. decompensated cirrhosis), or either AST or ALT 100 IU/L or higher during the observation times 7. Patients with severe renal impairment (e.g. renal failure), or serum creatinine 1.5 mg/dL or higher during the observation times 8. Patients with severe heart impairment (e.g. heart failure, unstable angina), or have myocardial infarct or angina attack within 24 weeks of the observation times 9. Stroke (cerebral infarction, brain hemorrhage) within 24 weeks before providing consent 10. Patients with malignancy 11. Patients with severe diabetic complications (neuropathy, retinopathy, and nephropathy) 12. Patients with severe ketosis, diabetic coma or precoma 13. Patients with endocrine disease which needs more than hormone replacement therapy (e.g. pituitary, thyroid, or adrenal disease) 14. Patients who have moderate to severe anemia (hemoglobin is below 9.5g/dL) 15. Patients with intestine disease which shows abnormality in digestion and absorption 16. Patients with a medical history digestive organ ablation (excepting cutting appendix) 17. Patients who are excessive alcohol drinkers (e.g. an average of 3 Go of Japanese wine, or 3 large bottles of beer, or more) 18. Patients with other reasons that the responsive investigators or other investigators think inappropriate to participate
研究者
相似试验
已完成
不适用
The study of ANagliptin effects on Glucagon LEvels of type 2 DM patients using insulin / ANGLE studyType 2 diabetes mellitusJPRN-UMIN000023414Juntendo University20
已完成
不适用
Effect of anagliptin on plasma glucagon levels determined by LC-MS/MS in patients with type 2 diabetesType 2 diabetesJPRN-UMIN000028293St. Marianna University School of Medicine24
已完成
不适用
Effect of glucagon-like-peptide-1 (GLP-1) on left ventricular function during percutaneous coronary intervention (PCI)ISRCTN77442023Papworth Hospital NHS Foundation Trust (UK)40
进行中（未招募）
1 期
Study of the counter-regulation to hypoglycemia during treatment with sitagliptin in subjects with type 2 diabetesType 2 Diabetes MellitusEUCTR2014-002685-70-SEund University
进行中（未招募）
不适用
Testing Whether Glucagon Solutions Affect the Glucose Levels in the Fat Tissue of Diabetic Patients.EUCTR2014-002341-22-ATMedizinische Universität Graz; Universitätsklinik für InnereMedizin; Abteilung für Endokrinologie und Stoffwechsel